T2DH34 Stock Overview
Provides virtual healthcare services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Teladoc Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.76 |
| 52 Week High | US$3.67 |
| 52 Week Low | US$1.24 |
| Beta | 0.90 |
| 11 Month Change | -2.22% |
| 3 Month Change | 34.35% |
| 1 Year Change | -37.14% |
| 33 Year Change | -92.04% |
| 5 Year Change | n/a |
| Change since IPO | -94.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| T2DH34 | BR Healthcare Services | BR Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -37.1% | 0% | 0% |
Return vs Industry: T2DH34 underperformed the BR Healthcare Services industry which returned 6.3% over the past year.
Return vs Market: T2DH34 underperformed the BR Market which returned -1.6% over the past year.
Price Volatility
| T2DH34 volatility | |
|---|---|
| T2DH34 Average Weekly Movement | 10.6% |
| Healthcare Services Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: T2DH34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: T2DH34's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 5,208 | Chuck Divita | www.teladochealth.com |
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Teladoc Health, Inc. Fundamentals Summary
| T2DH34 fundamental statistics | |
|---|---|
| Market cap | R$9.19b |
| Earnings (TTM) | -R$5.69b |
| Revenue (TTM) | R$15.01b |
0.6x
P/S Ratio-1.6x
P/E RatioIs T2DH34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| T2DH34 income statement (TTM) | |
|---|---|
| Revenue | US$2.59b |
| Cost of Revenue | US$755.77m |
| Gross Profit | US$1.83b |
| Other Expenses | US$2.82b |
| Earnings | -US$981.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.70 |
| Gross Margin | 70.82% |
| Net Profit Margin | -37.91% |
| Debt/Equity Ratio | 102.2% |
How did T2DH34 perform over the long term?
See historical performance and comparison